Werewolf Therapeutics (HOWL) Q1 2025 Earnings

11MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.46
-0.42
-0.38
-0.34

Details

Expected EPS
-0.403333
Actual EPS
-0.46
Surprise EPS
-0.06
Surprise Percent
+14.05%

Description

Werewolf Therapeutics (HOWL) has reported earnings of -0.46 per share for Q1 2025.

0 Comments

Share your thoughts